Back to search

Article

Silybin acts synergistically with mesenchymal stem cells to ameliorate R848-induced lupus-like disease in mice

2023-08-29

Abstract excerpt

<h4>Objective: </h4>  To determine the therapeutic effects of silybin (SBI) and its synergistic effects with mesenchymal stem cells (MSCs) in a lupus mouse model and to explore the therapeutic mechanisms. <h4>Methods:</h4>  TLR7/8 agonist resiquimod (R848) was applied for the induction of lupus mice. R848-induced B6 mice were randomly divided into a normal saline control group, SBI group, MSCs group, and SBI plus...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
10402918-b185-57f0-a4f8-d6d1caee5a55
DOI
10.22541/au.169330012.21637314/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Silybin acts synergistically with mesenchymal stem cells to ameliorate R848-induced lupus-like disease in miceDOI 10.22541/au.169330012.21637314/v1
Select a neighboring publication to make it the new centre.